Results 51 to 60 of about 346,856 (231)

Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers

Diagnostics, 2021
Easily accessible biomarkers are urgently needed to evaluate immune activation in Juvenile Dermatomyositis (JDM). The goal of this retrospective study is to define immunological and clinical differences between untreated JDM patients with either normal ...
Amer M. Khojah, Gabrielle A Morgan, L. Pachman   +2 more
semanticscholar   +1 more source

Nuclear matrix protein 2 antibody-positive adult dermatomyositis: a case report and review of the literature [PDF]

, 2020
Dermatomyositis is a clinically heterogenous inflammatory myopathy with unique cutaneous features. Myositis-specific antibodies can aid in diagnosis and anticipation of patient prognosis.
Cartron, Alexander M, Chung, Catherine, Osler, Montana, Trinidad, John C   +3 more
core  

Vitamin D supplementation in the pediatric rheumatology clinic. [PDF]

, 2011
Vitamin D is capturing the attention of healthy and chronically ill populations for its potential skeletal and nonskeletal benefits. New information suggesting a role in immune modulation has led to a surge of interest among rheumatologists. Although the
Burnham, Jon M, von Scheven, Emily
core   +3 more sources

A Case of Juvenile Dermatomyositis Manifesting Inflammatory Epidermal Nevus-Like Skin Lesions: Unrecognized Cutaneous Manifestation of Blaschkitis?

Allergology International, 2010
Background: Juvenile dermatomyositis is potentially life threatening rare autoimmune illness that mainly affects muscle and skin. Cutaneous features are useful in establishing the diagnosis of this disease.
Yuji Takahashi, Hiroyuki Murota, MasahitoTarutani, Shigetoshi Sano, Takeshi Okinaga, Koji Tominaga, Toshie Yano, Ichiro Katayama   +7 more
doaj   +1 more source

Juvenile dermatomyositis (JDM) and severe pulmonary involvement: case report [PDF]

, 2009
Juvenile dermatomyositis (JDM) is an inflammatory, non-pustular disorder of skeletal muscles and skin. Other organs, such as the lungs, can be involved.
Bugni, Vanessa Monteiro, Castro, Márcia Helena de Oliveira, Hilário, Maria Odete Esteves, Ishigai, Márcia Marcelino de Souza, Silva, Érika Cristina Carneiro da, Terreri, Maria Teresa Ramos Ascensão   +5 more
core   +2 more sources

Gene Expression Profiles of Treatment Response and Non‐Response in Children With Juvenile Dermatomyositis

ACR Open Rheumatology, 2022
The study objective was to identify differences in gene expression between treatment responders (TRs) and treatment non‐responders (TNRs) diagnosed with juvenile dermatomyositis (JDM).
C. Stingl, J. Dvergsten, Simon W M Eng, R. Yeung, M. Fritzler, T. Mason, C. Crowson, D. Voora, A. Reed   +8 more
semanticscholar   +1 more source

Juvenile Dermatomyositis: A 20-year Retrospective Analysis of Treatment and Clinical Outcomes

Pediatrics and Neonatology, 2015
Juvenile dermatomyositis is a rare childhood multisystem autoimmune disease involving primarily the skin and muscles, and it may lead to long-term disability.
Chi Sun, Jyh-Hong Lee, Yao-Hsu Yang, Hsin-Hui Yu, Li-Chieh Wang, Yu-Tsan Lin, Bor-Luen Chiang   +6 more
doaj   +1 more source

Favorable outcomes with reduced steroid use in juvenile dermatomyositis

Pediatric Rheumatology Online Journal, 2021
Background High-intensity glucocorticoid regimens are commonly used to induce and maintain remission in Juvenile Dermatomyositis but are associated with several adverse side-effects.
Amir B. Orandi, Lampros Fotis, Jamie Lai, Hallie Morris, Andrew J. White, Anthony R. French, Kevin W. Baszis   +6 more
doaj   +1 more source

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis [PDF]

, 2016
OBJECTIVE: To compare the abbreviated Cutaneous Assessment Tool (CAT), Disease Activity Score (DAS), and Myositis Intention to Treat Activity Index (MITAX) and correlate them with the physician's 10-cm skin visual analog scale (VAS) in order to define ...
Almeida, B, Arnold, K, Campanilho-Marques, R, de Iorio, M, Deakin, C, Gallot, N, Juvenile Dermatomyositis Research Group, ., Nistala, K, Pilkington, CA, Wedderburn, LR   +9 more
core   +1 more source

Anti-nuclear matrix protein 2 antibody-associated juvenile dermatomyositis with gastrointestinal perforations was successfully treated with traditional therapeutic drugs combined with vedolizumab: a case report after a long-term follow-up and a review of the literature

Frontiers in Pediatrics
Gastrointestinal perforation in patients with juvenile dermatomyositis has been reported as a life-threatening complication in the literature. However, effective treatment of juvenile dermatomyositis with gastrointestinal perforation remains challenging.
Xue-mei Xu, Shuang Ye, Ying-ying Jin, Chen-xi Liu, Sheng-fang Bao, Hua Huang, Fei Ding, Zhen Yang, Yan-liang Jin   +8 more
doaj   +1 more source